# A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors

> **NCT05254665** · PHASE2 · UNKNOWN · sponsor: **Jiangsu Simcere Pharmaceutical Co., Ltd.** · enrollment: 110 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Docetaxel Polymeric Micelles for Injection

## Key facts

- **NCT ID:** NCT05254665
- **Lead sponsor:** Jiangsu Simcere Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02
- **Primary completion:** 2022-12
- **Final completion:** 2024-03
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254665, "A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05254665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*